July update

propylthiouracil
Generic propylthiouracil
Pharmaceutical company:
DAVA Pharmaceuticals, Inc.
www.davapharma.com

Saw these articles and wish to share it with you

NEW WARNING
The Food and Drug Administration added a “Boxed Warning” to propylthiouracil prescribing information after reports of severe liver injury and acute liver failure in patients receiving the drug. Propylthiouracil is indicated for treatment of hyperthyroidism. The warning recommends reserving the drug for patients who are unable to tolerate other treatments such as methimazole (Tapazole), radioactive iodine, or surgery. Patients taking the drug should be advised to notify their health care provider if they develop fever, anorexia, nausea, vomiting, tiredness, pruritis, jaundice, or dark-colored urine.

Brought to you by Lippincott Williams & Wilkins.

Advertisement
This entry was posted in Drug Update. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s